Actually not what the Rat said at that last conference if I correctly recall. With the horrors of the fentanyl crisis, you never know if the the FDA may change its tune regarding the expensive tests needed to complete the protocol. I too would like one of our science gurus explain the import of the filing last week.
WRONG! Excerpt from the latest CC (November 15, 2022 11:30 AM ET) (rrr2003 post #375653) CEO NH --We have never withdrawn SequestOx. It’s still a pending application with the FDA. We just did not finish all of the clinical trials they ask us to do. That’ll cost tons of money, millions of dollars, but we cannot resubmit what has not been withdrawn. It’s still an active application. We have decided not to pursue it because of financials as I’ve explained many times before.